THYROCARE vs VIJAYA: Stock Comparison
VIJAYA DIAGNOSTIC CEN is the larger company by market capitalisation. THYROCARE TECH shows a lower P/E, a higher ROE and a higher dividend yield, while VIJAYA DIAGNOSTIC CEN shows faster revenue growth and a higher net margin. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Metric snapshot
THYROCARE leads 6; VIJAYA leads 6 of 13
Interactive comparison
Compare the numbers that shape the decision
Every row uses its own scale. Switch lenses to compare like with like.
Valuation lens
What price are you paying?
✓ marks the usual favourable reading; it is not a recommendation.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Profile
| Metric | THYROCARE | VIJAYA |
|---|---|---|
| Sector | Healthcare | Healthcare |
| Industry | Healthcare Service Provider | Healthcare Service Provider |
Price
| Metric | THYROCARE | VIJAYA |
|---|---|---|
| Live Price | ₹566.85 | ₹1,513.6 |
| Day Change | 0.02% | -0.85% |
| Volume | 1.29 L | 58,184 |
| 52-Week High | ₹1,610 | ₹1,593.6 |
| 52-Week Low | ₹342.55 | ₹848 |
| Distance from 52W High | -64.79% | -5.02% |
Valuation
| Metric | THYROCARE | VIJAYA |
|---|---|---|
| Market Cap | ₹9,009 Cr | ₹15,528 Cr |
| P/E Ratio | 51.08x | 82.71x |
| P/B Ratio | 15.38x | 16.21x |
| EPS | ₹3.15 | ₹5.16 |
| Book Value | ₹36.82 | ₹92.94 |
| Dividend Yield | 2.46% | 0.13% |
Growth
| Metric | THYROCARE | VIJAYA |
|---|---|---|
| Revenue Growth (TTM YoY) | 19.7% | 26.6% |
| EPS Growth (TTM YoY) | 116.3% | 38% |
| Qtr Sales Growth | -5.98% | -5.39% |
| Qtr Profit Growth | -2.26% | 0.09% |
Profitability & Leverage
| Metric | THYROCARE | VIJAYA |
|---|---|---|
| ROE | 27.79% | 18.9% |
| ROCE | 29.49% | 22.25% |
| Net Margin | 19.67% | 20.91% |
| Operating Margin | 25.85% | 34.91% |
| Debt to Equity | 0x | 0x |
Shareholding
As of Jun 2026 • change vs previous quarter| Metric | THYROCARE | VIJAYA |
|---|---|---|
| Promoter Holding | 60.92% | 52.47%▼ 0.04 pp |
| FII Holding | 5.44%▲ 0.07 pp | 11.65%▼ 1.73 pp |
| DII Holding | 20.92%▼ 0.07 pp | 31.58%▲ 1.65 pp |
| Public Holding | 12.72%▲ 0.01 pp | 4.31%▲ 0.13 pp |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: THYROCARE TECH and VIJAYA DIAGNOSTIC CEN.
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.